2024年11月19日 · Astellas Pharma Inc. announced the United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for avacincaptad pegol intravitreal solution (IZERVAY).

2025年1月3日 · The Data and Safety Monitoring Board (DSMB) for the OCU410 ArMaDa clinical trial convened and approved continuation of the second phase of the Phase 1/2 study.

2024年12月11日 · Exegenesis Bio provided an update on the company’s treatment candidates for wet age-related macular degeneration (wet AMD). EXG102 is an investigational gene therapy for wet AMD that is administered by subretinal injection.

2024年11月13日 · Imaging techniques to differentiate papilledema from ODD . Several different OCT measurements have been postulated to help differentiate ODD/pseudopapilledema from papilledema, such as RNFL thickness, macular ganglion cell–inner plexiform layer thickness, forward displacement of the Bruch membrane, and subretinal hyporeflective spacer.

2024年4月2日 · Age-related macular degeneration (AMD) is among the leading causes of vision loss. For this reason, many companies see the importance of developing treatment options that would allow patients to preserve or potentially regain some visual acuity.

2024年12月21日 · A research team from Great Britain identified factors, such as mental health issues, lack of diabetic eye screening awareness, and transport difficulties, that interfere with attendance at annual screenings by patients with diabetes and evaluated the adherence to guidelines set by the National Institute for Health and Care Excellence (NICE), 1 according to the lead author, Upamanyu Leo Chanda ...

2024年10月18日 · Thomas Aaberg, Jr, MD, Neurotech's Chief Medical Officer, shared some insights on the company's recent presentation as well as their upcoming presentations at the annual American Academy of Ophthalmology meeting being held in Chicago, Illinois.

2024年12月26日 · In 2024, Modern Retina covered news from around the globe on clinical trials, technology in retina, trending topics in ophthalmology, and retina conferences. Let’s look back on some of the top stories of the year as we gear up for an incredible 2025. GA and AMD. Age-related macular degeneration (AMD) and geographic atrophy (GA) continue to be major areas of development as researchers seek ...

2024年10月25日 · The results of a new retrospective cohort study suggest that use of curcuma-based nutritional supplements (CBNS) may be associated with the reduced risk of developing age-related macular degeneration (AMD) or progression to the later disease stages, 1 according to the first author Amer F. Alsoudi, MD, from the Department of Ophthalmology, Baylor College of Medicine, Houston.

2024年10月20日 · Christine N. Kay, MD, discussed her presentation, "Deuterated vitamin A preserves vision in Stargardt’s disease (TEASE study)" which was given at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.